Crescendo Biologics Ltd.
PrivateLast Round
VC Round
Jul 24, 2023
Total Funding Raised
$108.6M
Momentum Score
25 /100
Company Overview
Crescendo Biologics Ltd. is a clinical-stage immuno-oncology company that develops novel, targeted T-cell enhancing therapeutics based on its proprietary Humabody® VH platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Crescendo Biologics Ltd. Comps
Public and private peers based on sector, stage, and business model.
Crescendo Biologics Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 24, 2023 | ||||
| Series B | Apr 30, 2018 | ||||
| Series A | Dec 17, 2013 | ||||
| Seed | Oct 12, 2009 |
Crescendo Biologics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | VC Round |
| IP Group | VC Round, Series B |
| Andera Partners | VC Round, Series B |
| UK Innovation & Science Seed Fund | Seed |
| Imperial Innovations | Series A |
| Astellas Venture Management | Series A |
| Sofinnova Partners | VC Round, Series B, Series A, Seed |
Crescendo Biologics Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Crescendo Biologics Ltd.'s valuation, stock price, and market status.
